Illumina
Yahoo Finance • 12 days ago
The Ensign Group, Illumina, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a fur... Full story
Yahoo Finance • 12 days ago
LLY joins $1T club but doesn't feature in SA's top 10 large-cap healthcare stocks
[Lilly Biotechnology Center in San Diego, California, USA.] JHVEPhoto Eli Lilly (LLY [https://seekingalpha.com/symbol/LLY]) officially joined the elite group of U.S. companies valued at more than $1T on Friday, becoming the tenth American... Full story
Yahoo Finance • last month
Closing Bell Movers: Amazon soars to all-time highs on earnings
In the opening hour of the evening session, U.S. equity futures are notably higher, with S&P 500 up 0.5% and Nasdaq 100 contracts up 1.0%. In commodities, WTI Crude Oil is little changed just above $60 per barrel while precious metals are... Full story
Yahoo Finance • last month
Illumina Inc (ILMN) Q3 2025 Earnings Call Highlights: Strong EPS Growth and Strategic ...
This article first appeared on GuruFocus. Revenue: $1.08 billion, roughly flat year-over-year, exceeded guidance range. Non-GAAP Operating Margin: 24.5%, expanded by 190 basis points year-over-year. Non-GAAP Diluted EPS: $1.34, grew $0.20... Full story
Yahoo Finance • last month
Illumina outlines path to high single-digit revenue growth and 20% margins by 2027 amid NovaSeq X acceleration
Earnings Call Insights: Illumina, Inc. (ILMN) Q3 2025 MANAGEMENT VIEW * CEO Jacob Thaysen reported, "In the third quarter, we delivered another strong performance with revenue, non-GAAP operating margin and diluted EPS all above our gu... Full story
Yahoo Finance • last month
What To Expect From Illumina’s (ILMN) Q3 Earnings
Genomics company Illumina (NASDAQ:ILMN) will be reporting results this Thursday after market close. Here’s what to expect. Illumina beat analysts’ revenue expectations by 1% last quarter, reporting revenues of $1.06 billion, down 3% year... Full story
Yahoo Finance • 2 months ago
Roche Sets Gene-Sequencing Record. It’s a Challenge for Illumina.
The Broad Institute gene-sequencing lab used Roche equipment to read infants’ DNA genomes in less than four hours, cutting an hour off the previous Guinness World Record. Continue Reading View Comments... Full story
Yahoo Finance • 2 months ago
Opportunities in the Booming AI in Bioinformatics Market: A $26+ Billion Industry by 2029 Led by Thermo Fisher Scientific, Eurofins Scientific, Dassault Systemes, Illumina and NeoGenomics Laboratories
Company Logo Key market opportunities in AI bioinformatics include increased genomic data, precision medicine, biomarker discovery, and clinical trial optimization. Growth is driven by single-cell tech, multi-omics, and AI for drug repurp... Full story
Yahoo Finance • 2 months ago
Molecular Diagnostics Market Industry Trends and Global Forecasts to 2035 | Roche, Abbott, Thermo Fisher, and Illumina Among Key Players Shaping Molecular Diagnostics
Company Logo Molecular diagnostics offers rapid testing, crucial for personalized medicine and disease detection. Growth opportunities arise in segments like reagents, NGS technology, and infectious diseases. Expanding markets in Asia, ri... Full story
Yahoo Finance • 2 months ago
It isn’t your imagination; Google Cloud is flooding the zone
Image Credits:Viaframe The $100 billion partnership between Nvidia and OpenAI, announced Monday, represents – for now – the latest mega-deal reshaping the AI infrastructure landscape. The agreement involves non-voting shares tied to massi... Full story
Yahoo Finance • 2 months ago
Brown Advisory Global Leaders Strategy Exited Illumina (ILMN) in Q2. Here’s Why
Brown Advisory, an investment management company, released its “Brown Advisory Global Leaders Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The strategy focused on delivering strong long-term p... Full story
Yahoo Finance • 3 months ago
ILMN January 2028 Options Begin Trading
Investors in Illumina Inc (Symbol: ILMN) saw new options begin trading today, for the January 2028 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 858 days unti... Full story
Yahoo Finance • 3 months ago
Europe Non-Invasive Prenatal Testing Market Growth and Company Analysis Report 2025-2033 Featuring Eurofins Scientific, F. Hoffmann-La Roche, Invitae, Illumina, Natera, Centogene, and Qiagen
Dublin, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The "Europe Non-Invasive Prenatal Testing Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering. The Europe... Full story
Yahoo Finance • 3 months ago
Asia-Pacific Non-Invasive Prenatal Testing Market Growth and Company Analysis Report 2025-2033 Featuring Eurofins Scientific, F. Hoffmann-La Roche, Invitae, Illumina, Natera, Centogene, and Qiagen
Dublin, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Non-Invasive Prenatal Testing Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering. The... Full story
Yahoo Finance • 3 months ago
ILLUMINA INC (NASDAQ:ILMN) Screens as a Decent Value Stock for Investors
In value investing, the search for undervalued stocks often involves finding companies whose market price does not match their intrinsic worth, based on an analysis of financial health, profitability, growth potential, and valuation measur... Full story
Yahoo Finance • 3 months ago
MicroGenDX's New Testing Platform Cuts NGS Turnaround Time to 24 Hours for Life-Saving Decisions
Adoption of Illumina's MiSeq i100 Plus accelerates results delivery to next-day from sample receipt, speeding up patient care when time matters most. ORLANDO, FLORIDA / ACCESS Newswire / September 2, 2025 / MicroGenDX, a national pioneer... Full story
Yahoo Finance • 3 months ago
Liquid Biopsy Market Trends and Industry Forecast to 2030 Featuring Strategic Analysis of Natera, Guardant Health, Myriad Genetics, Illumina, and Roche Among Others
Company Logo Liquid Biopsy MarketLiquid Biopsy Market Dublin, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The "Liquid Biopsy Market by Product & Service (Kits, Instruments), Circulating Biomarker (ctDNA, cfDNA, CTC), Technology (NGS, PCR), Applic... Full story
Yahoo Finance • 4 months ago
Nilesh Shah joins Illumina as Head of Region, AMEA
SINGAPORE, Aug. 19, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the appointment of Nilesh Shah as Head of Region, AMEA, effective immediately.Nilesh Sha... Full story
Yahoo Finance • 4 months ago
Press Release Biocartis NV: Biocartis Welcomes Mike Kreitzinger as Senior Vice President of Global Business Development
Biocartis NV PRESS RELEASE - 08/18/2025, 09:00 AM EDT Biocartis Welcomes Mike Kreitzinger as Senior Vice President of Global Business Development Itasca (IL), United States, August 18th, 2025 – Biocartis Group of Companies (“Biocartis”)... Full story
Yahoo Finance • 4 months ago
Casdin funds buys Standard Biotools (LAB) shares worth $443,032
Casdin Partners Master Fund, L.P., along with other related entities, reported purchasing shares of Standard Biotools Inc. NASDAQ:LAB, totaling $443,032. The purchases, executed between August 13 and August 15, 2025, were made at prices ra... Full story
